Effects of androgen suppression by gonadotropin-releasing hormone agonist and flutamide on lipid metabolism in men with prostate cancer: Focus on lipoprotein(a)

Clinical Chemistry

Volumn 42, Issue 8, 1996, Pages 1176-1181

  Denti, L ^a   Pasolini, G ^a   Cortellini, P ^a   Ferretti, S ^a   Sanfelici, L ^a   Ablondi, F ^a   Valenti, G ^a  

^a Ospedale G Stuard   (Italy)

Author keywords

cluster analysis; flutamide; gonadotropins; goserelin; lipoproteins

Indexed keywords

ANDROGEN; ESTRADIOL; FLUTAMIDE; GOSERELIN; LIPOPROTEIN A; TESTOSTERONE;

ADULT; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER HORMONE THERAPY; CASTRATION; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; HORMONAL REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; LIPID METABOLISM; MALE; PROSTATE CANCER; TREATMENT OUTCOME;

EID: 0029740578     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinchem/42.8.1176     Document Type: Article

References (0)